Related Experiment Video
Updated: Jul 11, 2026

Enhanced Oil Recovery using a Combination of Biosurfactants
Published on: June 3, 2022
Novel phospholipase-resistant lipid/peptide synthetic lung surfactants
Robert H Notter1, Adrian L Schwan, Zhengdong Wang
1Department of Pediatrics, University of Rochester School of Medicine, 601 Elmwood Avenue, Rochester, NY 14642, USA. Robert_Notter@urmc.Rochester.edu
Abstract:
Animal-derived drugs are currently widely-used to treat clinical lung surfactant deficiency, but synthetic surfactants have significant advantages as pharmaceutical agents. This article examines exogenous surfactants containing novel synthetic phospholipase-resistant lipids of extremely high surface activity. Mixtures of these lipid analogs with purified native surfactant apoproteins are detailed as a proof of concept for related fully-synthetic surfactants containing laboratory-produced peptides. The chemistry and biophysics of relevant lipid analogs and peptides are reviewed in the context of developing new synthetic drugs of utility for patients with surfactant deficiency or lung injury-related surfactant dysfunction.
More Related Videos
Related Concept Videos
Breathing
Surface Active Agents
Micelles
Synthesis of Phosphatidylcholine in the ER Membrane
The major components of all eukaryotic cell...

